drugset / Trial / NCT02506023
Characterization of Laboratory Response to DDAVP in Adult Hemophilia A Carriers
Non-randomizedParallel-groupOpen-labelDiagnostic
Summary
The purpose of this study is to determine how female hemophilia A carriers respond to a medication called DDAVP (Desmopressin).
Timeline
- Start
- 2015-07
- Primary completion
- 2018-06-15
- Completion
- 2018-06-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Desmopressin | Peptide | 0.3 ug/kg | Intravenous |